Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

ESMO 21st World Congress on Gastrointestinal Cancer

3 - 7 Jul 2019
Centre de Convencions International de Barcelona, Barcelona, Spain
Immunotherapy with radiation in metastatic pancreatic and colorectal adenocarcin...
Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA
Immunotherapy with radiation in metastatic pancreatic and colorectal adenocarcinoma ( Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA )
15 Jul 2019
Using ctDNA to predict recurrence and response in colorectal cancer
Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA
Using ctDNA to predict recurrence and response in colorectal cancer ( Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA )
15 Jul 2019
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuv...
Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer ( Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany )
15 Jul 2019
Applied precision cancer medicine in advanced biliary tract cancer
Dr Hossein Taghizadeh - Medical University of Vienna, Vienna, Austria
Applied precision cancer medicine in advanced biliary tract cancer ( Dr Hossein Taghizadeh -  Medical University of Vienna, Vienna, Austria )
15 Jul 2019
Treating HER2-mutant advanced biliary tract cancer with neratinib
Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA
Treating HER2-mutant advanced biliary tract cancer with neratinib ( Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA )
15 Jul 2019
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients
Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan...
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )
15 Jul 2019
VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with local...
Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan
VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer ( Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan )
15 Jul 2019
TRIBE2: Latest data for patients with mCRC
Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
TRIBE2: Latest data for patients with mCRC ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
15 Jul 2019
Entrectinib in NTRK-fusion positive gastrointestinal cancers
Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy
Entrectinib in NTRK-fusion positive gastrointestinal cancers ( Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy )
15 Jul 2019
Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-l...
Prof Jean-Philippe Metges - Centre Hospitalier Régional et Universitaire de Bres...
Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-line therapy for advanced oesophageal cancer ( Prof Jean-Philippe Metges - Centre Hospitalier Régional et Universitaire de Brest, Brest, France )
15 Jul 2019
Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
Latest advances in pancreatic cancer treatment and impact on practice ( Prof Eric Van Cutsem and Dr Talia Golan )
10 Jul 2019